Vyome Holdings, Inc. (HIND)
2.22
-0.01
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
2.16
-0.06
(-2.70%)
After-Hours: 20:00
Vyome Holdings SG&A Expense (TTM) : 2.683M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.683M |
| March 31, 2026 | 4.492M |
| December 31, 2025 | 6.170M |
| September 30, 2025 | 6.614M |
| June 30, 2025 | 8.571M |
| March 31, 2025 | 9.186M |
| December 31, 2024 | 9.921M |
| September 30, 2024 | 11.48M |
| June 30, 2024 | 12.53M |
| March 31, 2024 | 14.36M |
| December 31, 2023 | 17.87M |
| September 30, 2023 | 20.74M |
| June 30, 2023 | 23.28M |
| March 31, 2023 | 28.66M |
| December 31, 2022 | 30.84M |
| September 30, 2022 | 33.28M |
| June 30, 2022 | 42.44M |
| March 31, 2022 | 38.19M |
| December 31, 2021 | 33.57M |
| September 30, 2021 | 29.24M |
| Date | Value |
|---|---|
| June 30, 2021 | 17.28M |
| March 31, 2021 | 14.90M |
| December 31, 2020 | 14.82M |
| September 30, 2020 | 14.50M |
| June 30, 2020 | 13.40M |
| March 31, 2020 | 14.36M |
| December 31, 2019 | 16.67M |
| September 30, 2019 | 19.88M |
| June 30, 2019 | 23.23M |
| March 31, 2019 | 26.14M |
| December 31, 2018 | 29.95M |
| September 30, 2018 | 32.32M |
| June 30, 2018 | 34.29M |
| March 31, 2018 | 32.90M |
| December 31, 2017 | 28.83M |
| September 30, 2017 | 24.44M |
| June 30, 2017 | 19.04M |
| March 31, 2017 | 13.18M |
| December 31, 2016 | 7.242M |
| September 30, 2016 | 2.412M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.4266M |
| Anika Therapeutics, Inc. | 52.67M |
| Enovis Corp. | 1.081B |
| Edwards Lifesciences Corp. | 2.201B |
| Perspective Therapeutics, Inc. | 29.46M |